Lutetium Lu 177 Vipivotide Tetraxetan: The Prostate Cancer Warrior's Secret Weapon

What Is Lutetium Lu 177 Vipivotide Tetraxetan?

Lutetium Lu 177 vipivotide tetraxetan (Pluvicto), a new drug, might help with advanced prostate cancer treatment. It targets cancer cells with radiation to stop them from spreading. Your doctor might suggest it if you've already tried other treatments like hormone therapy and chemo. The US FDA (Food and Drug Administration) approved it on March 23, 2022, for patients whose cancer is PSMA-positive (prostate-specific membrane antigen). Since it's radioactive, you'll get it through a vein.

Drug Group:

Lutetium Lu 177 vipivotide tetraxetan is a radiopharmaceutical drug. You'll find it being used as a radiolabeled peptide when doctors need to deliver targeted therapy right where it counts. It is part of your broader radiation oncology toolkit; these agents use radiation to destroy cancer cells.

Dosage Forms and Strengths

• Form: Liquid state.

• Strength: 1,000 MBq/mL or megabecquerels per milliliter (27 mCi/mL or millicuries per milliliter).

• Administration: Your doctor will give it as an IV (intravenous) injection at six-weekly intervals, with a maximum of six doses, depending on side effects.

For Patients:

Indications:

The indications are as follows:

• Lutetium Lu 177 vipivotide tetraxetan in prostate cancer treatment. If your prostate cancer has spread outside your prostate and it's called "PSMA-positive," you might qualify for this treatment. PSMA is a prostate-specific membrane antigen, a protein that is expressed on the surface of some prostate cancer cells.

• If your cancer worsens even after you've tried other treatments like hormone therapy and at least one round of chemotherapy.

Contraindication:

You should not use this drug if you have

• Allergic reaction to the drug.

• Pregnant or breastfeeding woman.

• Renal or hepatic disease.

• Cardiovascular disease.

• If you have bone marrow depression.

Limitations of Lutetium Lu 177 Vipivotide Tetraxetan:

There are some limitations of Lutetium Lu 177 vipivotide tetraxetan.

• Causes serious side effects, such as myelosuppression (where your bone marrow doesn't produce enough blood cells) and dry mouth, which can affect your daily life.

• Some patients have to stop treatment early because the side effects become too much to handle.

• This drug stops the development of cancer cells but does not eliminate them completely.

• This drug is very expensive.

How Is Lutetium Lu 177 Vipivotide Tetraxetan Used for Prostate Cancer?

Lutetium Lu 177 vipivotide is used for advanced prostate cancer treatment. This treatment is specifically designed for you if your prostate cancer has spread despite other therapies and tests positive for something called PSMA.

It attaches to cancer cells that have PSMA on their surface. Once it finds them, it delivers radiation right where it's needed most, directly to those cancer cells.

Your doctor will give you this treatment through an IV, typically once every 6 to 8 weeks. You can receive up to six doses total, depending on how your body responds and what your medical team recommends.

How Should Lutetium Lu 177 Vipivotide Tetraxetan Be Used?

You'll receive this medication from your doctor through an IV drip right into your vein.

You might get a dose once every 6 weeks, and you could receive up to 6 doses total. Your doctor will monitor how your body responds and watch for any side effects you might have. They'll adjust your treatment based on what works best for you.

This medication isn't meant for kids; it's only approved for adult patients.

What Are the Side Effects of Lutetium Lu 177 Vipivotide Tetraxetan?

Common Side Effects:

• Tiredness.

• Dry mouth.

• Nausea and vomiting.

• Appetite loss.

• Weight loss.

• Diarrhea.

• Joint pain.

• Constipation.

• Back pain.

• Headache.

Serious Side Effects:

• Kidney issues.

• Temporary or permanent infertility.

• Bleeding or bruising.

• Frequent infections with chills and fever.

• Low blood cell count.

• Pallor.

• Fatigue.

What Are the Things to Inform the Doctor Before Taking Lutetium Lu 177 Vipivotide Tetraxetan?

You should inform your doctor if:

• You are pregnant or breastfeeding.

• You have kidney or liver disease.

• You have an allergic reaction to Lutetium Lu 177 Vipivotide Tetraxetan.

• If you are taking any current medicines, you should tell your doctor about them.

• Make sure you tell your doctor about any ongoing infections, blood problems, or other serious health issues you're dealing with.

Overdose:

If you have taken too much, you need to call your doctor right away. Taking more than you should means you're getting extra radiation, which can be harmful or cause serious problems.

Missed Dose:

If you forgot to take your dose, call your doctor. It's important to stick to your dosing schedule because skipping doses can mess up your whole treatment plan.

Storage and Disposal:

Storage: Keep your medication at room temperature, which is between 68°F and 77°F (or 20°C and 25°C). Make sure it stays away from moisture and heat, and always store it in those special radiation-safe containers.

Disposal: You'll need to get rid of this through a licensed radioactive waste service; just follow your local rules. And don't forget to wear the right protective gear to avoid exposure to radiation.

For Doctors:

Clinical Pharmacology of Lutetium Lu 177 Vipivotide Tetraxetan:

Lutetium Lu 177 vipivotide tetraxetan is a cancer-fighting treatment that is designed to target specific cancer cells in your body. If you have cancer cells with somatostatin receptors, this therapy delivers radiation right where you need it most. It's designed to target harmful cancer cells while protecting healthy parts of your body from unnecessary radiation damage.

Mechanism of Action

Lutetium Lu 177 vipivotide tetraxetan is called radioligand therapy. This treatment hunts down specific cells in your body and zaps them with radiation until they're gone for good.

It goes after something called the PSMA protein that sits on your prostate cancer cells. Once Pluvicto finds and latches onto that protein, it's game over for those cancer cells, and the radiation takes them out.

Pharmacodynamics:

Lutetium Lu 177 vipivotide tetraxetan is basically a smart cancer treatment. How do some tumor cells have these special receptors on them? This treatment specifically targets those somatostatin receptor-positive cells.

It delivers radiation right to your tumor cells, damaging their DNA (deoxyribonucleic acid) and stopping them from growing. In many cases, it can even make your tumors shrink. The best part is that it's selective; if your tumor has lots of these somatostatin receptors, the treatment goes straight there and leaves most of your healthy tissues alone.

This treatment might help kick your immune system into gear to fight the tumor even more. It's mainly used when tumors show high levels of these specific receptors, making it a targeted approach rather than a one-size-fits-all solution.

Pharmacokinetics:

Lutetium Lu 177 vipivotide tetraxetan is a targeted treatment that targets cancer cells. When you get this therapy through your IV (intravenous), it goes straight to work, binding specifically to PSMA-positive cancer cells. Your body absorbs it completely and quickly.

About 44% of the non-radioactive portion attaches to proteins in your blood plasma.

• Distribution: Once it's in your system, the drug spreads throughout your body with an average distribution volume of 123 liters.

• Primary Route: Your kidneys do most of the heavy lifting in getting rid of this medication, and that is your body's main exit route.

• Elimination Half-life: It takes about 41.6 hours for half of the drug to leave your system.

• Clearance: Your blood clears the medication at an average rate of 2.04 liters per hour.

Drug Warnings and Precautions:

Pluvicto doesn't interact with other medications. But you should still let your healthcare team know about everything you're taking. That includes your prescription meds, anything you grabbed from the pharmacy shelf, vitamins, and herbal supplements.

Precautions:

• After radiation exposure, you'll need to keep some distance from others for a specific number of days. That means no hugging or close contact, and you'll especially want to stay away from pregnant women and kids during this time.

• Your kidneys and bone marrow need some extra attention, too. This treatment can affect different types of blood cells (a condition called myelosuppression), and it might also affect your kidney function. These are serious risks that your doctor will monitor closely.

• Pluvicto can cause permanent infertility, so if that's in your future plans, you might want to consider preserving your sperm before starting treatment.

• For male patients, this medication can harm a developing baby. You'll need to use reliable birth control for 14 weeks after your treatment ends.

Clinical Studies:

Lutetium Lu 177 vipivotide tetraxetan has been analyzed in clinical trials for the treatment of patients with neuroendocrine tumors that are somatostatin receptor-sensitive. These studies have demonstrated that it can cause the tumor to shrink, prevent the cancer from advancing, and prolong PFS in the group of patients who are otherwise untreated by conventional therapies.

The drug is effective in providing symptomatic relief from pain and also improves the quality of life of the patients, but the side effects include fatigue and renal toxicity. Therefore, the current work in progress is directed towards strengthening its safety profile and defining its most effective application, with particular attention to the possibility of concomitant use with other treatments.

It has gained attention as a promising option, particularly when combined with PSMA-targeted therapy, which allows precise delivery of treatment to prostate-specific membrane antigen-expressing cancer cells.

Use in Specific Populations

• Pregnancy:

If you're pregnant or could become pregnant, you shouldn't take Lutetium Lu 177 vipivotide tetraxetan because the radiation can seriously harm your baby or even cause a miscarriage. You'll need to prevent pregnancy during treatment, and if you think you might be pregnant, talk to your doctor right away about safer options.

• Lactation:

If you're breastfeeding, you can't use Lutetium Lu 177 vipivotide tetraxetan because it'll expose your baby to radiation through your breast milk, which could be harmful. You'll need to stop nursing before starting this treatment and shouldn't resume afterward. Talk to your doctor about safe feeding alternatives for your little one.

• Pediatric Population:

It is unknown if Lutetium Lu 177 vipivotide tetraxetan is safe or effective for kids, so you can't use it for your child. You'll want to talk with your doctor about other treatment options that are right for your child's age.

• Renal and Hepatic Impairment:

If you have serious kidney or liver problems, you shouldn't take this medication since your body processes it through these organs, which could make you sick. Your doctor will need to keep a close eye on your kidney and liver function during treatment and might give you something to protect your kidneys while you're on it.

• Geriatric Population:

If an older adult is taking Lutetium Lu 177 vipivotide tetraxetan, the doctor will need to monitor them extra carefully, especially if they've had kidney or liver problems, since their body might process the medication differently as they age.